Q2 2021 Glenmark Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q2 FY '21 Earnings Conference Call of Glenmark Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Jason D'souza. Thank you, and over to you, sir.
' -
Welcome to Glenmark's Q2 earnings call. First, the review of operations for the quarter ended September 30, 2020. For the second quarter of FY 2021, Glenmark's consolidated revenue was at INR 29,524.79 million, recording an increase of 4.88%. For the 6 months ended September 30, 2020, Glenmark's consolidated revenue was at INR 52,972.66 million, recording an increase of 3.10%. India business, sales from the formulation business in India for the second quarter was at INR 10,506.91 million, recording growth of 17.22%. The India business continued to outperform the industry growth and has grown consistently over the past several years.
As per
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |